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Abstract
Nitric oxide (•NO) is a ubiquitous diffusible messenger in the central nervous system. •NO and derived nitrogen species
may interact with catecholamines, thus, modifying not only its regulatory actions but also producing oxidants and free radicals
that are likely to trigger toxic pathways in the nervous system. Oxidative pathways and chain oxidation reactions triggered by
catecholamines may be broken by ascorbate and glutathione, of which there is ample supply in the brain. At the subcellular level,
mitochondria and cytosolic dopamine storage vesicles are likely to provide site-specific settings for •NO and catecholamines
interactions. Thus, a complex picture emerges in which the steady- state levels of the individual reactants, the rate constants of
the reactions involved, the oxygen tension, and the compartmentalization of reactions determine the biological significance of
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0he redox interactions between NO and dopamine metabolism in the brain. The physiological relevance of NO-driven chemical
odifications of dopamine and its derivatives and the ensuing free radical production are discussed in connection with the
eurodegeneration inherent in Parkinson’s disease.
2004 Elsevier Ireland Ltd. All rights reserved.
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. Introduction
Parkinson’s disease is one of the most prevalent
ge-associated neurodegenerative disorders character-
zed by the degeneration of neuromelanin-pigmented
opaminergic neurons in the pars compacta of the sub-
tantia nigra. Although the mechanisms underlying
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this disease are unknown, efforts towards the identi-
fication of the fundamental causes of Parkinsons’s dis-
ease are based on the recognition of unique features of
dopaminergic cells (Ebadi and Sharma, 2003; Man-
del et al., 2003): (1) the restriction of cell death to
the dopamine-producing neurons has focused much at-
tention on the dopamine molecule itself as an impor-
tant factor; (2) mitochondrial dysfunction and oxidative
stress appear to be two major contributors to degen-
eration of dopaminegic neurons; (3) •NO increases
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during the progress of Parkinson’s diseases as a result of
inflammation-like processes and fosters dopamine de-
pletion; the ensuing neurotoxicity is averted by nNOS
inhibitors; and (4) •NO participates in the etiology
of the disease as indicated by the protective effect
against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(MPTP)-induced dopaminergic degeneration observed
both in a mutant mice lacking the inducible nitric oxide
synthase (iNOS) (Klivenyi et al., 2000) and in a mutant
mice lacking the nNOS gene.
Despite the involvement of •NO in catecholamine
metabolism, the chemical interaction of dopamine and
its metabolites with •NO constitutes a source of neuro-
toxic molecules, which may contribute in the cellular
process leading to neurodegeneration. In this work, we
review some recent data on the redox interaction be-
tween •NO and dopamine and its derivatives as well
as the implications for the mitochondrial damage and
neurodegeneration associated with Parkinsons’s dis-
ease caused by these interactions.
1.1. Redox chemistry of NO with dopamine and
derivatives
•NO does not react directly with dopamine in anaer-
obic conditions (Laranjinha and Cadenas, 2002; Rettori
et al., 2002), but in the presence of O2 dopamine is read-
ily oxidized. The species thought responsible for this
reaction is the product of the trimolecular reaction of O2
w • • •
t
w
•
N
n
m
t
f
(
2
•
(4)
(5)
Concurring with dopamine oxidation, 3,4-
dihydroxyphenylacetic acid (DOPAC), a major
metabolite of dopamine resulting from two ox-
idative steps catalysed by monoamine oxidase
and aldehyde dehydrogenase in mitochondria, and
6-hydroxydopamine, a sympathetic neurotoxin, origi-
nated from the oxidation of dopamine, for very low
oxygen tensions undergo one-electron oxidation by
•NO forming the semiquinone and the nitroxyl anion
(NO−) (reaction (5)).
At the low •NO concentrations found in biologi-
cal systems electron abstraction is expected to be the
main dopamine oxidation pathway. The semiquinone
formed can undergo either an oxidative or a reductive
decay. Reaction with oxygen yields the quinone and
the superoxide anion (O2•−) (reaction (6)); the latter
can continue the oxidative chain by reacting with •NO,
at diffusion-controlled rates (k= 1.9× 1010 M−1 s−1)
and resulting in peroxynitrite (ONOO−) formation
(reaction (7)). Protonation of ONOO− to peroxyni-
trous acid (ONOOH) involves a cage reaction (re-
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Oith NO (reaction (1)), NO2, or at high NO concen-
rations (in the mM range) N2O3 (dinitrogen trioxide),
hich is the product of the reaction between •NO2 with
NO (reaction (2)). Concerning the products formed,
2O3—being a strong nitrosating agent—leads to
itrosation with the ensuing 6-nitrosodopamine for-
ation (reaction (3)), which slowly is converted
o 6-nitrodopamine, whereas •NO2 leads to the
ormation of the semiquinone radical (reaction
4)).
•NO + O2→ 2 •NO2 (1)
NO + •NO2→ N2O3 (2)
(3)ction (8)) containing both HO and NO2, which
an promote the one-electron oxidation of dopamine
r any of its derivatives to the semiquinone (reac-
ion (9)). Alternatively, the one-electron reduction of
he semiquinone species to the quinol can be ac-
omplished by cell reductants, such as ascorbate or
lutathione (reaction (10)) (Laranjinha and Cadenas,
002). If the local concentration of the semiquinone
pecies is high, disproportionation can occur (reaction
11)).
(6)
NO + O2•−→ ONOO− (7)
NOO− +H+→ ONOOH ↔ [HO• . . . NO2•]
(8)
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Besides the formation of dopamine oxidation prod-
ucts, which by themselves can be harmful for the
cell (see below), the interaction between •NO and
dopamine can be an important source of oxidants, such
as O2•− and ONOO−, or lead to the oxidation of an-
tioxidants, such as glutathione or ascorbate. Overall,
these can constitute an important source of oxidative
stress in the cell.
Taking in account that at the low •NO concentration
found in vivo the trimolecular reaction of •NO with
O2 is slow, the •NO-derived oxidant that is expected
to be more relevant for the oxidation of dopamine in
vivo is ONOO−. However, for those dopamine-derived
species that can be directly oxidized by •NO, this re-
action is potentially relevant, for it can evade the con-
trol by antioxidant systems, such as superoxide dis-
mutase (SOD). In fact, it has been shown that SOD,
by removing O2•−, protects dopamine from oxidation
by •NO and inhibits the formation of ONOO− under
aerobic conditions (Riobo´ et al., 2002). Interestingly,
Cu,Zn-SOD enhances semiquinone formation in anaer-
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(b) the electrophilic character of quinones derived from
dopamine oxidation that can directly damage several
cellular components including the mitochondrion; and
(c) dopamine chain oxidation that generates reactive
oxygen species in a self-propagated cycle driven by
O2•−.
Concerning the first pathway, the levels of MAO in
dopaminergic neurons are controversial, and probably
only low amounts of MAO are present in dopaminer-
gic cells (Hida et al., 1999). Moreover, independently
of the levels of MAO in dopaminergic neurons, if the
cytosolic dopamine concentration is taken into account
(≈1M) the reaction catalysed by MAO, which has
a KM≈ 650M (Hauptmann et al., 1996), will be
severely limited by the low dopamine concentration.
It can, thus, be estimated that the production of H2O2
by this pathway is not significant when compared with
other cellular sources of H2O2, such as mitochondrial
respiration (Antunes et al., 2002).
The potential harmful biological actions of elec-
trophilic species, such as quinones, is well documented
(Brunmark and Cadenas, 1989), but the mechanisms of
dopamine oxidation leading to electrophilic quinones
as well as their quantitative importance are difficult to
access. Concerning the initial step of dopamine oxi-
dation either O2•− or ONOO− are likely candidates.
Species like the hydroxyl radical or •NO2 may not be
formed in high enough amounts in order to be quan-
titatively important. A criterion to distinguish among
these species on their relative importance for dopamine
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fbiosis by a mechanism that may involve oxidation
f NO− back to •NO, hence increasing semiquinone
ormation (Laranjinha and Cadenas, 2002). Thus, un-
er such conditions Cu,Zn-SOD imposes a kinetic
ontrol of •NO -mediated DOPAC oxidation accom-
lished within a cycle involving the •NO→NO− tran-
ition during DOPAC oxidation (reaction (5)) and the
O−→•NO transition coupled to the reduction of
u2+ in superoxide dismutase.
.2. Biological relevance of NO and dopamine
hemical interactions
Dopamine damaging effects to the cell can be en-
isaged by the following general pathways: (a) the
roduction of H2O2 during the oxidative deamina-
ion of dopamine catalysed by monamine oxidase
MAO) present in the outer mitochondrial membrane;xidation is the intracellular localization of dopamine
n dopaminergic cells. The final steps of dopamine
ynthesis take place in the cytosol; once synthesized
opamine is rapidly transported via an ATP-dependent
rocess into storage vesicles (Flatmark, 2000). An im-
ortant characteristic of these vesicles is their acidic
H (approximately 5.5) which is thought to protect
opamine from oxidation, since the anion form of
opamine is the oxidizable form, while the protonated
orm is stabilized to oxidation. Nevertheless, due to the
210 F. Antunes et al. / Toxicology 208 (2005) 207–212
much higher concentration of dopamine in the storage
vesicles (>1 mM) compared with that in the cytosol
(Brautigam et al., 1985), the concentration of the anion
form of dopamine in the vesicles is expected to be ap-
proximately seventeen-fold higher than in the cytosol,
in spite of the low pH in the vesicles (Antunes et al.,
2002).
Thus, the oxidation of dopamine should be analyzed
not only in the cytosol but as well in the storage vesicles.
In the vesicles, the formation of superoxide is expect to
be slow, and its migration from the cytosol to these vesi-
cles is not probable to be significant because superox-
ide does not cross biomembranes, and so all superoxide
that could cross the membrane would be in the form of
the hydroperoxyl (Gus’kova et al., 1984), its protonated
form. On the other hand, there is evidence of physi-
cal association between storage vesicles and mitochon-
dria through tubular channels (Carmichael and Smith,
1978), and for the mitochondrial origin of the storage
vesicles (Issidorides et al., 1996). So, the possibility
of superoxide diffusing directly from mitochondria,
one of the main cellular sites concerning superoxide
production, to the vesicles should not be discarded.
Concerning •NO, it can cross biomembranes freely
(Subczynski et al., 1996), implying that the membrane
of the vesicles does not provide protection against NO
formed extracellularly or intracellularly. Once inside
these vesicles, •NO could react with the low amounts
of superoxide and form ONOO−, which could initi-
ate the oxidation of dopamine. Subsequently, this pro-
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idation in the cytosol can assume some relevance if the
storage is impaired leading to increased cytosolic levels
(Lotharius and Brundin, 2002).
In addition to dopamine oxidation, nitration by •NO
-derived nitrogen oxides (most likely N2O3) has been
reported to occur in vitro when •NO gas was bubbled
into an aerobic solution of the catecholamine (Daveu et
al., 1997). However, the high •NO concentration (up to
mM) required turns questionable its physiological rel-
evance even under inflammatory conditions (i.e., fol-
lowing expression of inducible iNOS in microglia and
astrocytes) in which •NO concentration is supposed to
increase.
Associated with dopamine oxidation there are well-
defined cellular effects that eventually could lead to
dopaminergic cell death. A central theme in this re-
gard is mitochondrial damage. Dopamine quinones
can directly damage the mitochondrion by impairing
the respiratory chain among other effects (Berman
and Hastings, 1999; Ben-Shachar et al., 1995). More-
over, dopamine can potentiate the •NO-damaging ef-
fect on the respiratory chain (Antunes et al., 2002),
causing apoptotic death in neurons by an early in-
sult to mitochondria (Wallace et al., 1997; Berman
and Hastings, 1999). An impaired mitochondrial res-
piration will cause a decrease ATP production, which
is absolutely necessary for the storage of dopamine in
the vesicles. This may cause an increase in the cytoso-
lic levels of dopamine, where dopamine oxidation is
more feasible than in the storage vesicles (Lothariusess could proceed in a self-propagated cycle formed
y reactions (6)–(9). In the storage vesicles, dopamine
xidation could be expected to be a significant local
ource of superoxide radicals. Independently, of the
recise mechanism there is now evidence of dopamine
xidation occurring in the storage vesicles, including
rocesses mediated by •NO (Antunes et al., 2002).
Concerning the cytosol, O2•− can be present in this
ite at high levels, namely through the leakage of super-
xide from the respiratory chain in a process controlled
y VDAC (Han et al., 2003). Therefore, the direct ini-
iation of dopamine oxidation by O2•− is a plausible
cenario. This oxidation could be increased in the pres-
nce of •NO via two pathways: (a) increase of superox-
de production caused by •NO acting on the respiratory
hain in an antimycin-like effect (Poderoso et al., 1996;
b) •NO interaction with superoxide forming ONOO−,
nd thus, initiating dopamine oxidation. Dopamine ox-and Brundin, 2002), further increasing the mitochon-
drial damage. In this context, it is also relevant to
note that dopamine quinones directly impair the uptake
of dopamine into the storage vesicles (Terland et al.,
1997). So, independent of the precise molecular mech-
anism involved, the basis for a self-propagated cycle
which amplifies the initial damage are set, leading ul-
timately to the death of the dopaminergic cell. It may
also be added that DOPAC potentiates •NO-induced
cell death in PC12 cells by mechanisms that are likely
to involve impairment of mitochondrial respiration (un-
published observations). This observation is in connec-
tion with the notion that mitochondria provides a site-
specific setting for the oxidation of DOPAC by •NO
(Laranjinha and Cadenas, 2002): First, DOPAC syn-
thesis is expected to occur in the mitochondrial matrix
via the activity of unspecific aldehyde dehydrogenase
(Ambroziak and Pietruszko, 1991; Tank et al., 1981);
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second, the steady-state level of •NO and O2•−, in the
mitochondrial matrix is expected to be high (Boveris et
al., 2000), contributing to peroxynitrite formation (re-
action (7)). Under these circumstances, the oxidation
of DOPAC by ONOO− may be an important source of
DOPAC semiquinone and ensuing redox transitions of
this species.
Overall, it may be surmised that the redox chemistry
described here involving, on the one hand, •NO and de-
rived nitrogen species and, on the other hand, dopamine
and DOPAC, may be a source of signals that positively
reinforce cellular pathways leading to cell death associ-
ated with Parkinson’s disease. Nevertheless, one should
also mention that glutathione and ascorbate, two an-
tioxidants abundant in the brain in the mM range, are
able to reduce o-semiquinones (Laranjinha and Cade-
nas, 2002) to the parent phenolic compounds (reac-
tion (10)). Thus, by favouring the reductive decay of
o-semiquinones, GSH and ascorbate prevent the forma-
tion of superoxide radical (reaction (6)) and the subse-
quent production of toxic species (reactions (7)–(9)).
Finally, compartmentalization of reactions, either in
vesicles or mitochondria, provides site-specific settings
that facilitate oxidation of catecholamines and ensuing
production of free radicals. A complex picture emerges
where the steady-state levels of the individual reactants,
the rate constants of the reactions involved, the oxygen
tension and the compartmentalization of reactions will
set the boundaries for dopamine and its metabolites as
•
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